Skip to main content
Erschienen in: Annals of Surgical Oncology 10/2018

02.07.2018 | Breast Oncology

Select Choices in Benign Breast Disease: An Initiative of the American Society of Breast Surgeons for the American Board of Internal Medicine Choosing Wisely® Campaign

verfasst von: Roshni Rao, MD, Kandace Ludwig, MD, Lisa Bailey, MD, Tiffany S. Berry, MD, Robert Buras, MD, Amy Degnim, MD, Oluwadamilola M. Fayanju, MD, Joshua Froman, MD, Negar Golesorkhi, MD, Caprice Greenburg, MD, Ayemoe Thu Ma, MD, Starr Koslow Mautner, MD, Helen Krontiras, MD, Michelle Sowden, DO, Barbara Wexelman, MD, Jeffrey Landercasper, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 10/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Up to 50% of all women encounter benign breast problems. In contrast to breast cancer, high-level evidence is not available to guide treatment. Management is therefore largely based on individual physician experience/training. The American board of internal medicine (ABIM) initiated its Choosing Wisely® campaign to promote conversations between patients and physicians about challenging the use of tests or procedures which may not be necessary. The American society of breast surgeons (ASBrS) Patient safety and quality committee (PSQC) chose to participate in this campaign in regard to the management of benign breast disease.

Methods

The PSQC solicited initial candidate measures. PSQC surgeons represent a wide variety of practices. The resulting measures were ranked by modified Delphi appropriateness methodology in two rounds. The final list was approved by ASBrS and endorsed by the ABIM.

Results

The final five measures are as follows. (1) Don’t routinely excise areas of pseuodoangiomatous stromal hyperplasia (PASH) of the breast in patients who are not having symptoms from it. (2) Don’t routinely surgically excise biopsy-proven fibroadenomas that are < 2 cm. (3) Don’t routinely operate for a breast abscess without an initial attempt to percutaneously aspirate. (4) Don’t perform screening mammography in asymptomatic patients with normal exams who have less than a 5-years life expectancy. (5) Don’t routinely drain nonpainful, fluid-filled cysts.

Conclusions

The ASBrS Choosing Wisely® measures that address benign breast disease management are easily accessible to patients via the internet. Consensus was reached by PSQC regarding these recommendations. These measures provide guidance for shared decision-making.
Literatur
1.
Zurück zum Zitat Levinson W, Kallewaard M, Bhatia RS, et al. “Choosing Wisely”: a growing international campaign. BMJ Qual Saf. 2015;24:167–74.CrossRefPubMed Levinson W, Kallewaard M, Bhatia RS, et al. “Choosing Wisely”: a growing international campaign. BMJ Qual Saf. 2015;24:167–74.CrossRefPubMed
2.
Zurück zum Zitat Landercasper J, Bailey L, Berry TS, et al. Measures of appropriateness and value for breast surgeons and their patients: the American Society of Breast Surgeons Choosing Wisely ((R)) Initiative. Ann Surg Oncol. 2016;23:3112–8.CrossRefPubMedPubMedCentral Landercasper J, Bailey L, Berry TS, et al. Measures of appropriateness and value for breast surgeons and their patients: the American Society of Breast Surgeons Choosing Wisely ((R)) Initiative. Ann Surg Oncol. 2016;23:3112–8.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat American College of O, Gynecologists’ Committee on Practice B-G. Practice Bulletin No. 164: diagnosis and management of benign breast disorders. Obstet Gynecol. 2016;127:e141–56.CrossRef American College of O, Gynecologists’ Committee on Practice B-G. Practice Bulletin No. 164: diagnosis and management of benign breast disorders. Obstet Gynecol. 2016;127:e141–56.CrossRef
4.
Zurück zum Zitat Morrow M. The evaluation of common breast problems. Am Fam Physician. 2000;61:2371–78, 2385. Morrow M. The evaluation of common breast problems. Am Fam Physician. 2000;61:2371–78, 2385.
5.
Zurück zum Zitat Fitch K. The Rand/UCLA appropriateness method user’s manual. Santa Monica: Rand, 2001. Fitch K. The Rand/UCLA appropriateness method user’s manual. Santa Monica: Rand, 2001.
6.
Zurück zum Zitat Drinka EK, Bargaje A, Ersahin CH, et al. Pseudoangiomatous stromal hyperplasia (PASH) of the breast: a clinicopathological study of 79 cases. Int J Surg Pathol. 2012;20:54–8.CrossRefPubMed Drinka EK, Bargaje A, Ersahin CH, et al. Pseudoangiomatous stromal hyperplasia (PASH) of the breast: a clinicopathological study of 79 cases. Int J Surg Pathol. 2012;20:54–8.CrossRefPubMed
7.
Zurück zum Zitat Hargaden GC, Yeh ED, Georgian-Smith D, et al. Analysis of the mammographic and sonographic features of pseudoangiomatous stromal hyperplasia. AJR Am J Roentgenol. 2008;191:359–63.CrossRefPubMed Hargaden GC, Yeh ED, Georgian-Smith D, et al. Analysis of the mammographic and sonographic features of pseudoangiomatous stromal hyperplasia. AJR Am J Roentgenol. 2008;191:359–63.CrossRefPubMed
8.
Zurück zum Zitat Amin AL, Purdy AC, Mattingly JD, Kong AL, Termuhlen PM. Benign breast disease. Surg Clin North Am. 2013;93:299–308.CrossRefPubMed Amin AL, Purdy AC, Mattingly JD, Kong AL, Termuhlen PM. Benign breast disease. Surg Clin North Am. 2013;93:299–308.CrossRefPubMed
9.
Zurück zum Zitat Lee S, Mercado CL, Cangiarella JF, Chhor CM. Frequency and outcomes of biopsy-proven fibroadenomas recommended for surgical excision. Clin Imaging. 2017;50:31–6.CrossRefPubMed Lee S, Mercado CL, Cangiarella JF, Chhor CM. Frequency and outcomes of biopsy-proven fibroadenomas recommended for surgical excision. Clin Imaging. 2017;50:31–6.CrossRefPubMed
10.
Zurück zum Zitat Hubbard JL, Cagle K, Davis JW, Kaups KL, Kodama M. Criteria for excision of suspected fibroadenomas of the breast. Am J Surg. 2015;209:297–301.CrossRefPubMed Hubbard JL, Cagle K, Davis JW, Kaups KL, Kodama M. Criteria for excision of suspected fibroadenomas of the breast. Am J Surg. 2015;209:297–301.CrossRefPubMed
11.
Zurück zum Zitat Kuijper A, Mommers EC, van der Wall E, van Diest PJ. Histopathology of fibroadenoma of the breast. Am J Clin Pathol. 2001;115:736–42.CrossRefPubMed Kuijper A, Mommers EC, van der Wall E, van Diest PJ. Histopathology of fibroadenoma of the breast. Am J Clin Pathol. 2001;115:736–42.CrossRefPubMed
12.
Zurück zum Zitat Trop I, Dugas A, David J, et al. Breast abscesses: evidence-based algorithms for diagnosis, management, and follow-up. Radiographics. 2011;31:1683–99.CrossRefPubMed Trop I, Dugas A, David J, et al. Breast abscesses: evidence-based algorithms for diagnosis, management, and follow-up. Radiographics. 2011;31:1683–99.CrossRefPubMed
13.
Zurück zum Zitat Lam E, Chan T, Wiseman SM. Breast abscess: evidence based management recommendations. Expert Rev Anti Infect Ther. 2014;12:753–62.CrossRefPubMed Lam E, Chan T, Wiseman SM. Breast abscess: evidence based management recommendations. Expert Rev Anti Infect Ther. 2014;12:753–62.CrossRefPubMed
14.
Zurück zum Zitat Eryilmaz R, Sahin M, Hakan Tekelioglu M, Daldal E. Management of lactational breast abscesses. Breast. 2005;14:375–9.CrossRefPubMed Eryilmaz R, Sahin M, Hakan Tekelioglu M, Daldal E. Management of lactational breast abscesses. Breast. 2005;14:375–9.CrossRefPubMed
15.
Zurück zum Zitat Naeem M, Rahimnajjad MK, Rahimnajjad NA, Ahmed QJ, Fazel PA, Owais M. Comparison of incision and drainage against needle aspiration for the treatment of breast abscess. Am Surg. 2012;78:1224–7.PubMed Naeem M, Rahimnajjad MK, Rahimnajjad NA, Ahmed QJ, Fazel PA, Owais M. Comparison of incision and drainage against needle aspiration for the treatment of breast abscess. Am Surg. 2012;78:1224–7.PubMed
16.
Zurück zum Zitat Myers ER, Moorman P, Gierisch JM, et al. Benefits and harms of breast cancer screening: a systematic review. JAMA. 2015;314:1615–34.CrossRefPubMed Myers ER, Moorman P, Gierisch JM, et al. Benefits and harms of breast cancer screening: a systematic review. JAMA. 2015;314:1615–34.CrossRefPubMed
17.
Zurück zum Zitat Lee CS, Moy L, Joe BN, Sickles EA, Niell BL. Screening for breast cancer in women age 75 years and older. AJR Am J Roentgenol. 2018;210:256–63.CrossRefPubMed Lee CS, Moy L, Joe BN, Sickles EA, Niell BL. Screening for breast cancer in women age 75 years and older. AJR Am J Roentgenol. 2018;210:256–63.CrossRefPubMed
18.
Zurück zum Zitat McPherson CP, Swenson KK, Lee MW. The effects of mammographic detection and comorbidity on the survival of older women with breast cancer. J Am Geriatr Soc. 2002;50:1061–8.CrossRefPubMed McPherson CP, Swenson KK, Lee MW. The effects of mammographic detection and comorbidity on the survival of older women with breast cancer. J Am Geriatr Soc. 2002;50:1061–8.CrossRefPubMed
20.
Zurück zum Zitat Rinaldi P, Ierardi C, Costantini M, et al. Cystic breast lesions: sonographic findings and clinical management. J Ultrasound Med. 2010;29:1617-26.CrossRefPubMed Rinaldi P, Ierardi C, Costantini M, et al. Cystic breast lesions: sonographic findings and clinical management. J Ultrasound Med. 2010;29:1617-26.CrossRefPubMed
22.
Zurück zum Zitat Brenner RJ, Bein ME, Sarti DA, Vinstein AL. Spontaneous regression of interval benign cysts of the breast. Radiology. 1994;193:365–8.CrossRefPubMed Brenner RJ, Bein ME, Sarti DA, Vinstein AL. Spontaneous regression of interval benign cysts of the breast. Radiology. 1994;193:365–8.CrossRefPubMed
23.
Zurück zum Zitat Porter ME, Teisberg EO. Redefining health care: creating value-based competition on results. Boston, MA: Harvard Business School Press, 2006. Porter ME, Teisberg EO. Redefining health care: creating value-based competition on results. Boston, MA: Harvard Business School Press, 2006.
24.
Zurück zum Zitat Fayanju OM, Mayo TL, Spinks TE, et al. Value-based breast cancer care: a multidisciplinary approach for defining patient-centered outcomes. Ann Surg Oncol. 2016;23:2385–90.CrossRefPubMed Fayanju OM, Mayo TL, Spinks TE, et al. Value-based breast cancer care: a multidisciplinary approach for defining patient-centered outcomes. Ann Surg Oncol. 2016;23:2385–90.CrossRefPubMed
Metadaten
Titel
Select Choices in Benign Breast Disease: An Initiative of the American Society of Breast Surgeons for the American Board of Internal Medicine Choosing Wisely® Campaign
verfasst von
Roshni Rao, MD
Kandace Ludwig, MD
Lisa Bailey, MD
Tiffany S. Berry, MD
Robert Buras, MD
Amy Degnim, MD
Oluwadamilola M. Fayanju, MD
Joshua Froman, MD
Negar Golesorkhi, MD
Caprice Greenburg, MD
Ayemoe Thu Ma, MD
Starr Koslow Mautner, MD
Helen Krontiras, MD
Michelle Sowden, DO
Barbara Wexelman, MD
Jeffrey Landercasper, MD
Publikationsdatum
02.07.2018
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 10/2018
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-018-6584-5

Weitere Artikel der Ausgabe 10/2018

Annals of Surgical Oncology 10/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.